Abstract:Introduction: Pancreatic cancer, or pancreatic duct adenocarcinoma (PDAC), remains one of the most lethal cancers and features insidious onset, highly aggressive behavior and early distant metastasis. The dense fibrotic stroma surrounding tumor cells is thought to be a shield to resist the permeation of chemotherapy drugs in the treatment of PDAC. Thus, we synthesized a pancreas-targeting paclitaxel-loaded PEGylated liposome and investigated its antitumor efficacy in the patient-derived orthotopic xenograft (PDOX) nude mouse models of PDAC. Methods: The PTX-loaded PEGylated liposomes were prepared by film dispersion-ultrasonic method and modified by an N,N-dimethyl tertiary amino residue. Morphology characteristics of the PTX-loaded liposomes were observed by transmission electron microscope (TEM). The PDOX models of PDAC were established by orthotopic implantation and imaged by a micro positron emission tomography/computed tomography (PET/CT) imaging system. The in vivo distribution and antitumor study were then carried out to observe the pancreas-targeting accumulation and the antitumor efficacy of the proposed PTX liposomes. Results: PTX loaded well into both modified (PTX-Lip2N) and unmodified (PTX-Lip) PEGylated liposomes with spherical shapes and suitable parameters for the endocytosis process. The PDOX nude mouse models were successfully created in which high F-18-FDG intaking regions were observed by micro-PET/CT. In addition to higher cellular uptakes of PTX-Lip2N by the BxPC-3 cells, the proposed nanoparticle had a notable penetrating ability towards PDAC tumor tissues, and consequently, the antitumor ability of PTX-Lip2N was significantly superior to the unmodified PTX-Lip in vivo PDOX models and even more effective than nab-PTX in restraining tumor growth. Conclusion: The modified pancreas-targeting PTX-loaded PEGylated liposomes provide a promising platform for the treatment of pancreatic cancer.

Alteration of nanomechanical properties of pancreatic cancer cells through anticancer drug treatment revealed by atomic force microscopy

Differences in Nanoparticle Uptake in Transplanted and Autochthonous Models of Pancreatic Cancer

Enhancement of Antitumor Efficacy of Paclitaxel-Loaded PEGylated Liposomes by N,N-Dimethyl Tertiary Amino Moiety in Pancreatic Cancer

Nanomechanical-based classification of prostate tumor using atomic force microscopy

Non-Invasive Detection of Biomechanical and Biochemical Responses of Human Lung Cells to Short Time Chemotherapy Exposure Using Afm and Confocal Raman Spectroscopy

Altered Mechanobiology of PDAC Cells with Acquired Chemoresistance to Gemcitabine and Paclitaxel

Biomechanical Profile of Cancer Stem-Like Cells Derived from MHCC97H Cell Lines.

Biointerface Mediates Cytoskeletal Rearrangement of Pancreatic Cancer Cell and Modulates Its Drug Sensitivity

Bio-Afm Of Cancer Cells And Multifunctional Theranostics

Dynamical Change of Cell Mechanical Properties Accompanying and Modulating Metastasis Process

Atomic Force Microscope Study of Tumor Cell Membranes Following Treatment with Anti-Cancer Drugs.

Alterations in mechanical properties are associated with prostate cancer progression

Pancreatic Ductal Adenocarcinoma Cortical Mechanics and Clinical Implications

A biomimetic nanodrug for enhanced chemotherapy of pancreatic tumors.

Studying the Effect of PDA@CeO2 Nanoparticles with Antioxidant Activity on the Mechanical Properties of Cells.

Atomic Force Microscopy for Tumor Research at Cell and Molecule Levels

Modulating Tumor Mechanics with Nanomedicine for Cancer Therapy

A Study on the Mechanics of Docetaxel on Lung Cancer Cells of A549 Using AFM

Application of Atomic Force Microscopy in Cancer Research

Cellular contractility and extracellular matrix stiffness regulate matrix metalloproteinase activity in pancreatic cancer cells

Mechanical Properties of Mouse Lung Cells and Their Effects on the Atomic Force Microscope Beam Vibrations